Obesity is a global epidemic and a major cause of morbidity and mortality because it increases the risk for comorbidities, including heart disease and fatty liver disease (MASLD). Read more
Medical News - Dec 24
This launch—and the recent cagrisema filing—should help Novo regain its footing against Lilly. Read more
Morningstar - Dec 23
You can't blame festive weight gain on eating scores of mince pies, fistfuls of Celebrations and double helpings of roast potatoes, a leading doctor has claimed. Read more
Mail Online - Dec 23
In some good health news for the state, adult and childhood obesity rates continue to decline, according to new data from the Centers for Disease Control and Prevention. Read more
Kfor - Dec 23
Expert Dr. Salas-Whalen reveals that body composition testing, not just the number on your scale, is key to knowing whether GLP-1 weight-loss medications are right for you. Read more
Fox News - Dec 21
CNBC's Annika Kim Constantino reports on Eli Lilly after the company said its closely watched obesity pill helped patients maintain the majority of their weight loss after they switched directly from taking the company’s injection Zepbound and Novo Nordisk’s rival shot Wegovy in a late-stage trial. Read more
Cnbc - Dec 18
Novo Nordisk A/S (NYSE:NVO) on Thursday submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for once-weekly CagriSema.The application covers CagriSema for use with a reduced-calorie diet and increased physical activity to treat obesity or overweight in the presen... Read more
Benzinga - Dec 18
This study protocol outlines a 12-week randomized trial testing whether a MIND diet intervention is feasible, acceptable, and sustainable for adults with obesity in Sweden. It will generate preliminary evidence on adherence, mental well-being, and gut microbiota changes to inform larger efficacy ... Read more
Medical News - Dec 15
Scientists found that certain molecules made by gut bacteria travel to the liver and help control how the body uses energy. These molecules change depending on diet, genetics, and shifts in the microbiome. Some even improved insulin response in liver cells when tested in the lab. The findings cou... Read more
Science Daily - Dec 14
Congress has the power to make obesity treatment and weight management accessible to the communities that need it. Read more
The Hill - Dec 13
